Clinical trials recruiting for Acute Chest Syndrome
4
Recruiting trials
2
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 1Phase 3 1Not applicable 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Injection of iohexol for glomerular filtration rate (GFR) measurement | 1 |
| Tocilizumab | 1 |
| Tocilizumab (RoActemra®, 20 mg/mL). | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Illinois | 1 |
| Indiana | 1 |
Top cities
Self-screener
Recruiting trials
- Efficacy and Safety of Tocilizumab for Acute Chest Syndrome Treatment in Patients With Sickle Cell Disease
- Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care
- Tocilizumab for Acute Chest Syndrome
- Ultrasound Acute Chest Syndrome Sickle Cell Disease
Related conditions
Trials recruiting for Acute Chest Syndrome often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Acute Chest Syndrome trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.